BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20501760)

  • 21. Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3): the multiethnic cohort.
    DeLellis K; Rinaldi S; Kaaks RJ; Kolonel LN; Henderson B; Le Marchand L
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1444-51. PubMed ID: 15342444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer.
    Lukanova A; Zeleniuch-Jacquotte A; Lundin E; Micheli A; Arslan AA; Rinaldi S; Muti P; Lenner P; Koenig KL; Biessy C; Krogh V; Riboli E; Shore RE; Stattin P; Berrino F; Hallmans G; Toniolo P; Kaaks R
    Int J Cancer; 2004 Jan; 108(2):262-8. PubMed ID: 14639613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition.
    Jenab M; Riboli E; Cleveland RJ; Norat T; Rinaldi S; Nieters A; Biessy C; Tjønneland A; Olsen A; Overvad K; Grønbaek H; Clavel-Chapelon F; Boutron-Ruault MC; Linseisen J; Boeing H; Pischon T; Trichopoulos D; Oikonomou E; Trichopoulou A; Panico S; Vineis P; Berrino F; Tumino R; Masala G; Peters PH; van Gils CH; Bueno-de-Mesquita HB; Ocké MC; Lund E; Mendez MA; Tormo MJ; Barricarte A; Martínez-García C; Dorronsoro M; Quirós JR; Hallmans G; Palmqvist R; Berglund G; Manjer J; Key T; Allen NE; Bingham S; Khaw KT; Cust A; Kaaks R
    Int J Cancer; 2007 Jul; 121(2):368-76. PubMed ID: 17372899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps.
    Schoen RE; Weissfeld JL; Kuller LH; Thaete FL; Evans RW; Hayes RB; Rosen CJ
    Gastroenterology; 2005 Aug; 129(2):464-75. PubMed ID: 16083703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma insulin-like growth factors, insulin-like binding protein-3, and outcome in metastatic colorectal cancer: results from intergroup trial N9741.
    Fuchs CS; Goldberg RM; Sargent DJ; Meyerhardt JA; Wolpin BM; Green EM; Pitot HC; Pollak M
    Clin Cancer Res; 2008 Dec; 14(24):8263-9. PubMed ID: 19073970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating insulin-like growth factor-related biomarkers: Correlates and responses to calcium supplementation in colorectal adenoma patients.
    Um CY; Fedirko V; Flanders WD; Höflich C; Wirthgen E; Bostick RM
    Mol Carcinog; 2017 Sep; 56(9):2127-2134. PubMed ID: 28467661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic variants, prediagnostic circulating levels of insulin-like growth factors, insulin, and glucose and the risk of colorectal cancer: the Multiethnic Cohort study.
    Ollberding NJ; Cheng I; Wilkens LR; Henderson BE; Pollak MN; Kolonel LN; Le Marchand L
    Cancer Epidemiol Biomarkers Prev; 2012 May; 21(5):810-20. PubMed ID: 22354904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-risk colorectal adenomas and serum insulin-like growth factors.
    Renehan AG; Painter JE; Atkin WS; Potten CS; Shalet SM; O'Dwyer ST
    Br J Surg; 2001 Jan; 88(1):107-13. PubMed ID: 11136321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Serum concentration of insulin, C-peptide and insulin-like growth factor I in patients with colon adenomas and colorectal cancer].
    Kaczka A; Kumor A; Pietruczuk M; Małecka-Panas E
    Pol Merkur Lekarski; 2007 May; 22(131):373-5. PubMed ID: 17679371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Association of insulin, insulin-like growth factor and insulin-like growth factor binding proteins with the risk of colorectal cancer].
    Jiang B; Liu DB; Zhang X; DU LL; Han CZ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):264-8. PubMed ID: 19434535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer.
    Keinan-Boker L; Bueno De Mesquita HB; Kaaks R; Van Gils CH; Van Noord PA; Rinaldi S; Riboli E; Seidell JC; Grobbee DE; Peeters PH
    Int J Cancer; 2003 Aug; 106(1):90-5. PubMed ID: 12794762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions between plasma levels of 25-hydroxyvitamin D, insulin-like growth factor (IGF)-1 and C-peptide with risk of colorectal cancer.
    Wu K; Feskanich D; Fuchs CS; Chan AT; Willett WC; Hollis BW; Pollak MN; Giovannucci E
    PLoS One; 2011; 6(12):e28520. PubMed ID: 22216097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma.
    Gao Y; Katki H; Graubard B; Pollak M; Martin M; Tao Y; Schoen RE; Church T; Hayes RB; Greene MH; Berndt SI
    Int J Cancer; 2012 Jul; 131(2):E105-13. PubMed ID: 21932422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-like growth factor (IGF)-I, IGF-II, IGF binding protein-3, and risk of colorectal cancer: a nested case-control study in the Japan Collaborative Cohort study.
    Suzuki S; Kojima M; Tokudome S; Suzuki K; Ozasa K; Ito Y; Inaba Y; Tajima K; Nakachi K; Watanabe Y; Tamakoshi A;
    Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():45-9. PubMed ID: 20553081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating levels of IGF-1, IGFBP-3, and IGF-1/IGFBP-3 molar ratio and colorectal adenomas: A meta-analysis.
    Yoon YS; Keum N; Zhang X; Cho E; Giovannucci EL
    Cancer Epidemiol; 2015 Dec; 39(6):1026-35. PubMed ID: 26388613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.
    Ma J; Pollak MN; Giovannucci E; Chan JM; Tao Y; Hennekens CH; Stampfer MJ
    J Natl Cancer Inst; 1999 Apr; 91(7):620-5. PubMed ID: 10203281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition.
    Cust AE; Allen NE; Rinaldi S; Dossus L; Friedenreich C; Olsen A; Tjønneland A; Overvad K; Clavel-Chapelon F; Boutron-Ruault MC; Linseisen J; Chang-Claude J; Boeing H; Schulz M; Benetou V; Trichopoulou A; Trichopoulos D; Palli D; Berrino F; Tumino R; Mattiello A; Vineis P; Quirós JR; Agudo A; Sánchez MJ; Larrañaga N; Navarro C; Ardanaz E; Bueno-de-Mesquita HB; Peeters PH; van Gils CH; Bingham S; Khaw KT; Key T; Slimani N; Riboli E; Kaaks R
    Int J Cancer; 2007 Jun; 120(12):2656-64. PubMed ID: 17285578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IGF-I and mammographic density in four geographic locations: a pooled analysis.
    Maskarinec G; Takata Y; Chen Z; Gram IT; Nagata C; Pagano I; Hayashi K; Arendell L; Skeie G; Rinaldi S; Kaaks R
    Int J Cancer; 2007 Oct; 121(8):1786-92. PubMed ID: 17520679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men.
    Ma J; Giovannucci E; Pollak M; Chan JM; Gaziano JM; Willett W; Stampfer MJ
    J Natl Cancer Inst; 2001 Sep; 93(17):1330-6. PubMed ID: 11535708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possible roles of insulin, IGF-1 and IGFBPs in initiation and progression of colorectal cancer.
    Jiang B; Zhang X; Du LL; Wang Y; Liu DB; Han CZ; Jing JX; Zhao XW; Xu XQ
    World J Gastroenterol; 2014 Feb; 20(6):1608-13. PubMed ID: 24587638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.